Invention Grant
US07930024B2 Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias 有权
减少怀疑非致命性心律失常的不适当的治疗方法

  • Patent Title: Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias
  • Patent Title (中): 减少怀疑非致命性心律失常的不适当的治疗方法
  • Application No.: US10755185
    Application Date: 2004-01-08
  • Publication No.: US07930024B2
    Publication Date: 2011-04-19
  • Inventor: Kevin T. Ousdigian
  • Applicant: Kevin T. Ousdigian
  • Applicant Address: US MN Minneapolis
  • Assignee: Medtronic, Inc.
  • Current Assignee: Medtronic, Inc.
  • Current Assignee Address: US MN Minneapolis
  • Agent Michael J. Ostrom; Stephen W. Baver
  • Main IPC: A61N1/365
  • IPC: A61N1/365 A61B5/0464
Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias
Abstract:
An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).
Information query
Patent Agency Ranking
0/0